Indication
Recurrent Non-Small Cell Lung Carcinoma
11 clinical trials
9 products
12 drugs
Product
CarboplatinDrug
TiragolumabClinical trial
A Phase IIa Trial of sEphB4-HSA in Combination With Anti PD-1 Antibody (Pembrolizumab, MK3475) in Patients With Non-small Cell Lung and Head/Neck CancerStatus: Active (not recruiting), Estimated PCD: 2025-03-10
Product
PembrolizumabClinical trial
A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients With Advanced, EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC)Status: Active (not recruiting), Estimated PCD: 2018-09-25
Product
AfatinibProduct
CetuximabClinical trial
A Phase I-II Trial of Combined PKCι and mTOR Inhibition for Patients With Advanced or Recurrent Lung Cancer (NSCLC and SCLC) Without Standard Treatment OptionsStatus: Completed, Estimated PCD: 2023-04-24
Product
AuranofinProduct
SirolimusClinical trial
Phase II Study of Weekly Vinorelbine and Paclitaxel in Elderly Patients With Advanced Non-Small Cell Lung CancerStatus: Completed, Estimated PCD: 2014-08-01
Clinical trial
Immune Response in Patients With Recurrent or Metastatic Non-small Cell Lung Cancer and Performance Status of 2 Treated With a Combination of Pembrolizumab and Low Dose Weekly Carboplatin/PaclitaxelStatus: Completed, Estimated PCD: 2022-11-19
Clinical trial
A Phase I/II Open-Label Study of Nimotuzumab in Combination With Nivolumab in Patients With Advanced Non-small Cell Lung CancerStatus: Completed, Estimated PCD: 2021-04-15
Drug
NimotuzumabDrug
T-VECClinical trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III TrialStatus: Active (not recruiting), Estimated PCD: 2023-12-20
Drug
DocetaxelDrug
GemcitabineProduct
PemetrexedDrug
ErlotinibClinical trial
Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLCStatus: Active (not recruiting), Estimated PCD: 2019-04-16
Drug
AN0025Drug
MetforminClinical trial
Study of Regorafenib in Combination With Oral Methotrexate for KRAS Mutated Non-Small Cell Lung Cancer (NSCLC)Status: Completed, Estimated PCD: 2022-06-15
Drug
RegorafenibClinical trial
Phase II Pilot Study Evaluating Strategies to Overcome Resistance at the Time of Progression for Patients With Non-small Cell Lung Cancers Harboring Major Oncogenic DriversStatus: Terminated, Estimated PCD: 2018-01-08
Drug
EnvafolimabDrug
mFOLFOX6Product
Targeted Molecular TherapyDrug
TKI